|
|
Volumn 9, Issue 1, 2000, Pages 129-146
|
|
Therapeutic and chemical developments of cholecystokinin receptor ligands
a
|
|
Author keywords
Brain gut hormone; CCK A receptor; CCK B receptor; CCK receptors agonists; Cck receptors antagonists; Cholecystokinin; CNS disorders; Gastrointestinal disorders; Pancreatic diseases
|
|
Indexed keywords
A 71378;
AR R15849;
BENZOTRIPT;
BETA ENDORPHIN;
CAM 1481;
CERULETIDE;
CHOLECYSTOKININ;
CHOLECYSTOKININ A RECEPTOR;
CHOLECYSTOKININ B RECEPTOR;
CHOLECYSTOKININ RECEPTOR;
CHOLECYSTOKININ RECEPTOR BLOCKING AGENT;
CHOLECYSTOKININ RECEPTOR STIMULATING AGENT;
DEVAZEPIDE;
G PROTEIN COUPLED RECEPTOR;
GW 5823;
GW 7178;
IQM 95333;
LORGLUMIDE;
LOXIGLUMIDE;
LY 219057;
MORPHINE;
N TERT BUTYLOXYCARBONYLTRYPTOPHYL[NEPSILON (2 METHYLPHENYLAMINOCARBONYL)LYSYL]ASPARTYL N METHYLPHENYLALANINAMIDE;
N [1 (2 FLUOROPHENYL) 3,4,6,7 TETRAHYDRO 4 OXOPYRROLO[3,2,1 JK][1,4]BENZODIAZEPIN 3 YL] 1H INDOLE 2 CARBOXAMIDE;
PROGLUMIDE;
RECEPTOR SUBTYPE;
SC 50998;
T 0632;
TP 680;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
CENTRAL NERVOUS SYSTEM DISEASE;
DRUG ANTAGONISM;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
GASTROINTESTINAL DISEASE;
HUMAN;
IRRITABLE COLON;
NONHUMAN;
PANCREATITIS;
REVIEW;
|
|
EID: 0033986943
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.1.129 Document Type: Review |
|
Times cited : (44)
|
|
References (111)
|
